Global Stem Cell Drugs Market Growth 2020-2025
Apr, 2020
|
Report ID: 128290
|
137
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Stem Cell Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Stem Cell Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Drugs market by type, application, key manufacturers and key regions and countries.
This study considers the Stem Cell Drugs value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cord Blood-Derived
Adipose-Derived
Bone Marrow-Derived
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Graft-versus-Host Disease
Crohns Disease
Amyotrophic Lateral Sclerosis
Osteoarthritis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
JCR Pharmaceuticals Co., Ltd
CORESTEM, Inc
Anterogen
Chiesi Pharmaceuticals
Pharmicell Co., Ltd
MEDIPOST
Takeda
New York Blood Center
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Stem Cell Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Stem Cell Drugs market by identifying its various subsegments.
Focuses on the key global Stem Cell Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Stem Cell Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Stem Cell Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Drugs market by type, application, key manufacturers and key regions and countries.
This study considers the Stem Cell Drugs value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cord Blood-Derived
Adipose-Derived
Bone Marrow-Derived
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Graft-versus-Host Disease
Crohns Disease
Amyotrophic Lateral Sclerosis
Osteoarthritis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
JCR Pharmaceuticals Co., Ltd
CORESTEM, Inc
Anterogen
Chiesi Pharmaceuticals
Pharmicell Co., Ltd
MEDIPOST
Takeda
New York Blood Center
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Stem Cell Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Stem Cell Drugs market by identifying its various subsegments.
Focuses on the key global Stem Cell Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Stem Cell Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Stem Cell Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Stem Cell Drugs Consumption 2015-2025
2.1.2 Stem Cell Drugs Consumption CAGR by Region
2.2 Stem Cell Drugs Segment by Type
2.2.1 Cord Blood-Derived
2.2.2 Adipose-Derived
2.2.3 Bone Marrow-Derived
2.2.4 Others
2.3 Stem Cell Drugs Consumption by Type
2.3.1 Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Stem Cell Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Stem Cell Drugs Sale Price by Type (2015-2020)
2.4 Stem Cell Drugs Segment by Application
2.4.1 Acute Graft-versus-Host Disease
2.4.2 Crohns Disease
2.4.3 Amyotrophic Lateral Sclerosis
2.4.4 Osteoarthritis
2.4.5 Others
2.5 Stem Cell Drugs Consumption by Application
2.5.1 Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Stem Cell Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Stem Cell Drugs Sale Price by Type (2015-2020)
3 Global Stem Cell Drugs by Company
3.1 Global Stem Cell Drugs Sales Market Share by Company
3.1.1 Global Stem Cell Drugs Sales by Company (2018-2020)
3.1.2 Global Stem Cell Drugs Sales Market Share by Company (2018-2020)
3.2 Global Stem Cell Drugs Revenue Market Share by Company
3.2.1 Global Stem Cell Drugs Revenue by Company (2018-2020)
3.2.2 Global Stem Cell Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Stem Cell Drugs Sale Price by Company
3.4 Global Stem Cell Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Stem Cell Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Stem Cell Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Stem Cell Drugs by Regions
4.1 Stem Cell Drugs by Regions
4.2 Americas Stem Cell Drugs Consumption Growth
4.3 APAC Stem Cell Drugs Consumption Growth
4.4 Europe Stem Cell Drugs Consumption Growth
4.5 Middle East & Africa Stem Cell Drugs Consumption Growth
5 Americas
5.1 Americas Stem Cell Drugs Consumption by Countries
5.1.1 Americas Stem Cell Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Stem Cell Drugs Value by Countries (2015-2020)
5.2 Americas Stem Cell Drugs Consumption by Type
5.3 Americas Stem Cell Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Stem Cell Drugs Consumption by Regions
6.1.1 APAC Stem Cell Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Stem Cell Drugs Value by Regions (2015-2020)
6.2 APAC Stem Cell Drugs Consumption by Type
6.3 APAC Stem Cell Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Stem Cell Drugs by Countries
7.1.1 Europe Stem Cell Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Stem Cell Drugs Value by Countries (2015-2020)
7.2 Europe Stem Cell Drugs Consumption by Type
7.3 Europe Stem Cell Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Stem Cell Drugs by Countries
8.1.1 Middle East & Africa Stem Cell Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Stem Cell Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Stem Cell Drugs Consumption by Type
8.3 Middle East & Africa Stem Cell Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Stem Cell Drugs Distributors
10.3 Stem Cell Drugs Customer
11 Global Stem Cell Drugs Market Forecast
11.1 Global Stem Cell Drugs Consumption Forecast (2021-2025)
11.2 Global Stem Cell Drugs Forecast by Regions
11.2.1 Global Stem Cell Drugs Forecast by Regions (2021-2025)
11.2.2 Global Stem Cell Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Stem Cell Drugs Forecast by Type
11.8 Global Stem Cell Drugs Forecast by Application
12 Key Players Analysis
12.1 JCR Pharmaceuticals Co., Ltd
12.1.1 Company Information
12.1.2 Stem Cell Drugs Product Offered
12.1.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 JCR Pharmaceuticals Co., Ltd Latest Developments
12.2 CORESTEM, Inc
12.2.1 Company Information
12.2.2 Stem Cell Drugs Product Offered
12.2.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CORESTEM, Inc Latest Developments
12.3 Anterogen
12.3.1 Company Information
12.3.2 Stem Cell Drugs Product Offered
12.3.3 Anterogen Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Anterogen Latest Developments
12.4 Chiesi Pharmaceuticals
12.4.1 Company Information
12.4.2 Stem Cell Drugs Product Offered
12.4.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Chiesi Pharmaceuticals Latest Developments
12.5 Pharmicell Co., Ltd
12.5.1 Company Information
12.5.2 Stem Cell Drugs Product Offered
12.5.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pharmicell Co., Ltd Latest Developments
12.6 MEDIPOST
12.6.1 Company Information
12.6.2 Stem Cell Drugs Product Offered
12.6.3 MEDIPOST Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 MEDIPOST Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Stem Cell Drugs Product Offered
12.7.3 Takeda Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 New York Blood Center
12.8.1 Company Information
12.8.2 Stem Cell Drugs Product Offered
12.8.3 New York Blood Center Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 New York Blood Center Latest Developments
13 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Stem Cell Drugs Consumption 2015-2025
2.1.2 Stem Cell Drugs Consumption CAGR by Region
2.2 Stem Cell Drugs Segment by Type
2.2.1 Cord Blood-Derived
2.2.2 Adipose-Derived
2.2.3 Bone Marrow-Derived
2.2.4 Others
2.3 Stem Cell Drugs Consumption by Type
2.3.1 Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Stem Cell Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Stem Cell Drugs Sale Price by Type (2015-2020)
2.4 Stem Cell Drugs Segment by Application
2.4.1 Acute Graft-versus-Host Disease
2.4.2 Crohns Disease
2.4.3 Amyotrophic Lateral Sclerosis
2.4.4 Osteoarthritis
2.4.5 Others
2.5 Stem Cell Drugs Consumption by Application
2.5.1 Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Stem Cell Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Stem Cell Drugs Sale Price by Type (2015-2020)
3 Global Stem Cell Drugs by Company
3.1 Global Stem Cell Drugs Sales Market Share by Company
3.1.1 Global Stem Cell Drugs Sales by Company (2018-2020)
3.1.2 Global Stem Cell Drugs Sales Market Share by Company (2018-2020)
3.2 Global Stem Cell Drugs Revenue Market Share by Company
3.2.1 Global Stem Cell Drugs Revenue by Company (2018-2020)
3.2.2 Global Stem Cell Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Stem Cell Drugs Sale Price by Company
3.4 Global Stem Cell Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Stem Cell Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Stem Cell Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Stem Cell Drugs by Regions
4.1 Stem Cell Drugs by Regions
4.2 Americas Stem Cell Drugs Consumption Growth
4.3 APAC Stem Cell Drugs Consumption Growth
4.4 Europe Stem Cell Drugs Consumption Growth
4.5 Middle East & Africa Stem Cell Drugs Consumption Growth
5 Americas
5.1 Americas Stem Cell Drugs Consumption by Countries
5.1.1 Americas Stem Cell Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Stem Cell Drugs Value by Countries (2015-2020)
5.2 Americas Stem Cell Drugs Consumption by Type
5.3 Americas Stem Cell Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Stem Cell Drugs Consumption by Regions
6.1.1 APAC Stem Cell Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Stem Cell Drugs Value by Regions (2015-2020)
6.2 APAC Stem Cell Drugs Consumption by Type
6.3 APAC Stem Cell Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Stem Cell Drugs by Countries
7.1.1 Europe Stem Cell Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Stem Cell Drugs Value by Countries (2015-2020)
7.2 Europe Stem Cell Drugs Consumption by Type
7.3 Europe Stem Cell Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Stem Cell Drugs by Countries
8.1.1 Middle East & Africa Stem Cell Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Stem Cell Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Stem Cell Drugs Consumption by Type
8.3 Middle East & Africa Stem Cell Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Stem Cell Drugs Distributors
10.3 Stem Cell Drugs Customer
11 Global Stem Cell Drugs Market Forecast
11.1 Global Stem Cell Drugs Consumption Forecast (2021-2025)
11.2 Global Stem Cell Drugs Forecast by Regions
11.2.1 Global Stem Cell Drugs Forecast by Regions (2021-2025)
11.2.2 Global Stem Cell Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Stem Cell Drugs Forecast by Type
11.8 Global Stem Cell Drugs Forecast by Application
12 Key Players Analysis
12.1 JCR Pharmaceuticals Co., Ltd
12.1.1 Company Information
12.1.2 Stem Cell Drugs Product Offered
12.1.3 JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 JCR Pharmaceuticals Co., Ltd Latest Developments
12.2 CORESTEM, Inc
12.2.1 Company Information
12.2.2 Stem Cell Drugs Product Offered
12.2.3 CORESTEM, Inc Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CORESTEM, Inc Latest Developments
12.3 Anterogen
12.3.1 Company Information
12.3.2 Stem Cell Drugs Product Offered
12.3.3 Anterogen Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Anterogen Latest Developments
12.4 Chiesi Pharmaceuticals
12.4.1 Company Information
12.4.2 Stem Cell Drugs Product Offered
12.4.3 Chiesi Pharmaceuticals Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Chiesi Pharmaceuticals Latest Developments
12.5 Pharmicell Co., Ltd
12.5.1 Company Information
12.5.2 Stem Cell Drugs Product Offered
12.5.3 Pharmicell Co., Ltd Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Pharmicell Co., Ltd Latest Developments
12.6 MEDIPOST
12.6.1 Company Information
12.6.2 Stem Cell Drugs Product Offered
12.6.3 MEDIPOST Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 MEDIPOST Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Stem Cell Drugs Product Offered
12.7.3 Takeda Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 New York Blood Center
12.8.1 Company Information
12.8.2 Stem Cell Drugs Product Offered
12.8.3 New York Blood Center Stem Cell Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 New York Blood Center Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Stem Cell Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Cord Blood-Derived
Table 5. Major Players of Adipose-Derived
Table 6. Major Players of Bone Marrow-Derived
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 10. Global Stem Cell Drugs Revenue by Type (2015-2020) ($ million)
Table 11. Global Stem Cell Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Stem Cell Drugs Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 15. Global Stem Cell Drugs Value by Application (2015-2020)
Table 16. Global Stem Cell Drugs Value Market Share by Application (2015-2020)
Table 17. Global Stem Cell Drugs Sale Price by Application (2015-2020)
Table 18. Global Stem Cell Drugs Sales by Company (2017-2019) (K Units)
Table 19. Global Stem Cell Drugs Sales Market Share by Company (2017-2019)
Table 20. Global Stem Cell Drugs Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Stem Cell Drugs Revenue Market Share by Company (2017-2019)
Table 22. Global Stem Cell Drugs Sale Price by Company (2017-2019)
Table 23. Global Stem Cell Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Stem Cell Drugs Products Offered
Table 25. Stem Cell Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Stem Cell Drugs Consumption by Regions 2015-2020 (K Units)
Table 27. Global Stem Cell Drugs Consumption Market Share by Regions 2015-2020
Table 28. Global Stem Cell Drugs Value by Regions 2015-2020 ($ Millions)
Table 29. Global Stem Cell Drugs Value Market Share by Regions 2015-2020
Table 30. Americas Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 32. Americas Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 34. Americas Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 35. Americas Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 36. Americas Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 37. Americas Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 38. APAC Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 40. APAC Stem Cell Drugs Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Stem Cell Drugs Value Market Share by Regions (2015-2020)
Table 42. APAC Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 43. APAC Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 44. APAC Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 45. APAC Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 46. Europe Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 48. Europe Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 50. Europe Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 51. Europe Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 52. Europe Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 53. Europe Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 62. Stem Cell Drugs Distributors List
Table 63. Stem Cell Drugs Customer List
Table 64. Global Stem Cell Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Stem Cell Drugs Consumption Market Forecast by Regions
Table 66. Global Stem Cell Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Stem Cell Drugs Value Market Share Forecast by Regions
Table 68. Global Stem Cell Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Stem Cell Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Stem Cell Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Stem Cell Drugs Value Market Share Forecast by Type (2021-2025)
Table 72. Global Stem Cell Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Stem Cell Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Stem Cell Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Stem Cell Drugs Value Market Share Forecast by Application (2021-2025)
Table 76. JCR Pharmaceuticals Co., Ltd Product Offered
Table 77. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. JCR Pharmaceuticals Co., Ltd Main Business
Table 79. JCR Pharmaceuticals Co., Ltd Latest Developments
Table 80. JCR Pharmaceuticals Co., Ltd Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. CORESTEM, Inc Product Offered
Table 82. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. CORESTEM, Inc Main Business
Table 84. CORESTEM, Inc Latest Developments
Table 85. CORESTEM, Inc Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Anterogen Product Offered
Table 87. Anterogen Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Anterogen Main Business
Table 89. Anterogen Latest Developments
Table 90. Anterogen Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Chiesi Pharmaceuticals Product Offered
Table 92. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Chiesi Pharmaceuticals Main Business
Table 94. Chiesi Pharmaceuticals Latest Developments
Table 95. Chiesi Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Pharmicell Co., Ltd Product Offered
Table 97. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Pharmicell Co., Ltd Main Business
Table 99. Pharmicell Co., Ltd Latest Developments
Table 100. Pharmicell Co., Ltd Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. MEDIPOST Product Offered
Table 102. MEDIPOST Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. MEDIPOST Main Business
Table 104. MEDIPOST Latest Developments
Table 105. MEDIPOST Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Takeda Product Offered
Table 107. Takeda Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Takeda Main Business
Table 109. Takeda Latest Developments
Table 110. Takeda Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. New York Blood Center Product Offered
Table 112. New York Blood Center Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. New York Blood Center Main Business
Table 114. New York Blood Center Latest Developments
Table 115. New York Blood Center Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Stem Cell Drugs
Figure 2. Stem Cell Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Stem Cell Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Stem Cell Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cord Blood-Derived
Figure 7. Product Picture of Adipose-Derived
Figure 8. Product Picture of Bone Marrow-Derived
Figure 9. Product Picture of Others
Figure 10. Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Figure 11. Global Stem Cell Drugs Value Market Share by Type (2015-2020)
Figure 12. Stem Cell Drugs Consumed in Acute Graft-versus-Host Disease
Figure 13. Global Stem Cell Drugs Market: Acute Graft-versus-Host Disease (2015-2020) (K Units)
Figure 14. Global Stem Cell Drugs Market: Acute Graft-versus-Host Disease (2015-2020) ($ Millions)
Figure 15. Stem Cell Drugs Consumed in Crohns Disease
Figure 16. Global Stem Cell Drugs Market: Crohns Disease (2015-2020) (K Units)
Figure 17. Global Stem Cell Drugs Market: Crohns Disease (2015-2020) ($ Millions)
Figure 18. Stem Cell Drugs Consumed in Amyotrophic Lateral Sclerosis
Figure 19. Global Stem Cell Drugs Market: Amyotrophic Lateral Sclerosis (2015-2020) (K Units)
Figure 20. Global Stem Cell Drugs Market: Amyotrophic Lateral Sclerosis (2015-2020) ($ Millions)
Figure 21. Stem Cell Drugs Consumed in Osteoarthritis
Figure 22. Global Stem Cell Drugs Market: Osteoarthritis (2015-2020) (K Units)
Figure 23. Global Stem Cell Drugs Market: Osteoarthritis (2015-2020) ($ Millions)
Figure 24. Stem Cell Drugs Consumed in Others
Figure 25. Global Stem Cell Drugs Market: Others (2015-2020) (K Units)
Figure 26. Global Stem Cell Drugs Market: Others (2015-2020) ($ Millions)
Figure 27. Global Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Figure 28. Global Stem Cell Drugs Value Market Share by Application (2015-2020)
Figure 29. Global Stem Cell Drugs Sales Market Share by Company in 2017
Figure 30. Global Stem Cell Drugs Sales Market Share by Company in 2019
Figure 31. Global Stem Cell Drugs Revenue Market Share by Company in 2017
Figure 32. Global Stem Cell Drugs Revenue Market Share by Company in 2019
Figure 33. Global Stem Cell Drugs Sale Price by Company in 2019
Figure 34. Global Stem Cell Drugs Consumption Market Share by Regions 2015-2020
Figure 35. Global Stem Cell Drugs Value Market Share by Regions 2015-2020
Figure 36. Americas Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 37. Americas Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 38. APAC Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 39. APAC Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 40. Europe Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 41. Europe Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 44. Americas Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 45. Americas Stem Cell Drugs Value Market Share by Countries in 2019
Figure 46. Americas Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 47. Americas Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 48. United States Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 49. United States Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. Canada Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 55. APAC Stem Cell Drugs Value Market Share by Regions in 2019
Figure 56. APAC Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 57. APAC Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 58. China Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. China Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Japan Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 63. Korea Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. India Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. India Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. Australia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 71. Europe Stem Cell Drugs Value Market Share by Countries in 2019
Figure 72. Europe Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 73. Europe Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 74. Germany Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Germany Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. France Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 77. France Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. UK Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 79. UK Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Italy Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. Russia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Stem Cell Drugs Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 88. Egypt Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 93. Israel Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 98. Global Stem Cell Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global Stem Cell Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 101. Americas Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 102. APAC Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 103. APAC Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 104. Europe Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 105. Europe Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 108. United States Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 109. United States Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 110. Canada Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 111. Canada Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 112. Mexico Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 113. Mexico Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 114. Brazil Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 115. Brazil Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 116. China Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 117. China Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 118. Japan Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 119. Japan Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 120. Korea Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 121. Korea Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 124. India Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 125. India Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 126. Australia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 127. Australia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 128. Germany Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 129. Germany Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 130. France Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 131. France Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 132. UK Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 133. UK Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 134. Italy Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 135. Italy Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 136. Russia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 137. Russia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 138. Spain Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 139. Spain Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 140. Egypt Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 141. Egypt Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 142. South Africa Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 143. South Africa Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 144. Israel Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 145. Israel Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 146. Turkey Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 147. Turkey Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 149. GCC Countries Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 150. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Market Share (2018-2020)
Figure 151. CORESTEM, Inc Stem Cell Drugs Market Share (2018-2020)
Figure 152. Anterogen Stem Cell Drugs Market Share (2018-2020)
Figure 153. Chiesi Pharmaceuticals Stem Cell Drugs Market Share (2018-2020)
Figure 154. Pharmicell Co., Ltd Stem Cell Drugs Market Share (2018-2020)
Figure 155. MEDIPOST Stem Cell Drugs Market Share (2018-2020)
Figure 156. Takeda Stem Cell Drugs Market Share (2018-2020)
Figure 157. New York Blood Center Stem Cell Drugs Market Share (2018-2020)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Stem Cell Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Cord Blood-Derived
Table 5. Major Players of Adipose-Derived
Table 6. Major Players of Bone Marrow-Derived
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 10. Global Stem Cell Drugs Revenue by Type (2015-2020) ($ million)
Table 11. Global Stem Cell Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Stem Cell Drugs Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 15. Global Stem Cell Drugs Value by Application (2015-2020)
Table 16. Global Stem Cell Drugs Value Market Share by Application (2015-2020)
Table 17. Global Stem Cell Drugs Sale Price by Application (2015-2020)
Table 18. Global Stem Cell Drugs Sales by Company (2017-2019) (K Units)
Table 19. Global Stem Cell Drugs Sales Market Share by Company (2017-2019)
Table 20. Global Stem Cell Drugs Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Stem Cell Drugs Revenue Market Share by Company (2017-2019)
Table 22. Global Stem Cell Drugs Sale Price by Company (2017-2019)
Table 23. Global Stem Cell Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Stem Cell Drugs Products Offered
Table 25. Stem Cell Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Stem Cell Drugs Consumption by Regions 2015-2020 (K Units)
Table 27. Global Stem Cell Drugs Consumption Market Share by Regions 2015-2020
Table 28. Global Stem Cell Drugs Value by Regions 2015-2020 ($ Millions)
Table 29. Global Stem Cell Drugs Value Market Share by Regions 2015-2020
Table 30. Americas Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 32. Americas Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 34. Americas Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 35. Americas Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 36. Americas Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 37. Americas Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 38. APAC Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 40. APAC Stem Cell Drugs Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Stem Cell Drugs Value Market Share by Regions (2015-2020)
Table 42. APAC Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 43. APAC Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 44. APAC Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 45. APAC Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 46. Europe Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 48. Europe Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 50. Europe Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 51. Europe Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 52. Europe Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 53. Europe Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Stem Cell Drugs Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Stem Cell Drugs Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Stem Cell Drugs Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Stem Cell Drugs Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Stem Cell Drugs Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Stem Cell Drugs Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Table 62. Stem Cell Drugs Distributors List
Table 63. Stem Cell Drugs Customer List
Table 64. Global Stem Cell Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Stem Cell Drugs Consumption Market Forecast by Regions
Table 66. Global Stem Cell Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Stem Cell Drugs Value Market Share Forecast by Regions
Table 68. Global Stem Cell Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Stem Cell Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Stem Cell Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Stem Cell Drugs Value Market Share Forecast by Type (2021-2025)
Table 72. Global Stem Cell Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Stem Cell Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Stem Cell Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Stem Cell Drugs Value Market Share Forecast by Application (2021-2025)
Table 76. JCR Pharmaceuticals Co., Ltd Product Offered
Table 77. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. JCR Pharmaceuticals Co., Ltd Main Business
Table 79. JCR Pharmaceuticals Co., Ltd Latest Developments
Table 80. JCR Pharmaceuticals Co., Ltd Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. CORESTEM, Inc Product Offered
Table 82. CORESTEM, Inc Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. CORESTEM, Inc Main Business
Table 84. CORESTEM, Inc Latest Developments
Table 85. CORESTEM, Inc Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Anterogen Product Offered
Table 87. Anterogen Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Anterogen Main Business
Table 89. Anterogen Latest Developments
Table 90. Anterogen Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Chiesi Pharmaceuticals Product Offered
Table 92. Chiesi Pharmaceuticals Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Chiesi Pharmaceuticals Main Business
Table 94. Chiesi Pharmaceuticals Latest Developments
Table 95. Chiesi Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Pharmicell Co., Ltd Product Offered
Table 97. Pharmicell Co., Ltd Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Pharmicell Co., Ltd Main Business
Table 99. Pharmicell Co., Ltd Latest Developments
Table 100. Pharmicell Co., Ltd Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. MEDIPOST Product Offered
Table 102. MEDIPOST Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. MEDIPOST Main Business
Table 104. MEDIPOST Latest Developments
Table 105. MEDIPOST Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Takeda Product Offered
Table 107. Takeda Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Takeda Main Business
Table 109. Takeda Latest Developments
Table 110. Takeda Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. New York Blood Center Product Offered
Table 112. New York Blood Center Stem Cell Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. New York Blood Center Main Business
Table 114. New York Blood Center Latest Developments
Table 115. New York Blood Center Basic Information, Company Total Revenue (in $ million), Stem Cell Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Stem Cell Drugs
Figure 2. Stem Cell Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Stem Cell Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Stem Cell Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cord Blood-Derived
Figure 7. Product Picture of Adipose-Derived
Figure 8. Product Picture of Bone Marrow-Derived
Figure 9. Product Picture of Others
Figure 10. Global Stem Cell Drugs Consumption Market Share by Type (2015-2020)
Figure 11. Global Stem Cell Drugs Value Market Share by Type (2015-2020)
Figure 12. Stem Cell Drugs Consumed in Acute Graft-versus-Host Disease
Figure 13. Global Stem Cell Drugs Market: Acute Graft-versus-Host Disease (2015-2020) (K Units)
Figure 14. Global Stem Cell Drugs Market: Acute Graft-versus-Host Disease (2015-2020) ($ Millions)
Figure 15. Stem Cell Drugs Consumed in Crohns Disease
Figure 16. Global Stem Cell Drugs Market: Crohns Disease (2015-2020) (K Units)
Figure 17. Global Stem Cell Drugs Market: Crohns Disease (2015-2020) ($ Millions)
Figure 18. Stem Cell Drugs Consumed in Amyotrophic Lateral Sclerosis
Figure 19. Global Stem Cell Drugs Market: Amyotrophic Lateral Sclerosis (2015-2020) (K Units)
Figure 20. Global Stem Cell Drugs Market: Amyotrophic Lateral Sclerosis (2015-2020) ($ Millions)
Figure 21. Stem Cell Drugs Consumed in Osteoarthritis
Figure 22. Global Stem Cell Drugs Market: Osteoarthritis (2015-2020) (K Units)
Figure 23. Global Stem Cell Drugs Market: Osteoarthritis (2015-2020) ($ Millions)
Figure 24. Stem Cell Drugs Consumed in Others
Figure 25. Global Stem Cell Drugs Market: Others (2015-2020) (K Units)
Figure 26. Global Stem Cell Drugs Market: Others (2015-2020) ($ Millions)
Figure 27. Global Stem Cell Drugs Consumption Market Share by Application (2015-2020)
Figure 28. Global Stem Cell Drugs Value Market Share by Application (2015-2020)
Figure 29. Global Stem Cell Drugs Sales Market Share by Company in 2017
Figure 30. Global Stem Cell Drugs Sales Market Share by Company in 2019
Figure 31. Global Stem Cell Drugs Revenue Market Share by Company in 2017
Figure 32. Global Stem Cell Drugs Revenue Market Share by Company in 2019
Figure 33. Global Stem Cell Drugs Sale Price by Company in 2019
Figure 34. Global Stem Cell Drugs Consumption Market Share by Regions 2015-2020
Figure 35. Global Stem Cell Drugs Value Market Share by Regions 2015-2020
Figure 36. Americas Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 37. Americas Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 38. APAC Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 39. APAC Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 40. Europe Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 41. Europe Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Stem Cell Drugs Consumption 2015-2020 (K Units)
Figure 43. Middle East & Africa Stem Cell Drugs Value 2015-2020 ($ Millions)
Figure 44. Americas Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 45. Americas Stem Cell Drugs Value Market Share by Countries in 2019
Figure 46. Americas Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 47. Americas Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 48. United States Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 49. United States Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 51. Canada Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 53. Mexico Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 55. APAC Stem Cell Drugs Value Market Share by Regions in 2019
Figure 56. APAC Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 57. APAC Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 58. China Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. China Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 61. Japan Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 63. Korea Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 65. Southeast Asia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. India Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. India Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. Australia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 71. Europe Stem Cell Drugs Value Market Share by Countries in 2019
Figure 72. Europe Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 73. Europe Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 74. Germany Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Germany Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. France Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 77. France Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. UK Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 79. UK Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Italy Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. Russia Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Stem Cell Drugs Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Stem Cell Drugs Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Stem Cell Drugs Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Stem Cell Drugs Consumption Market Share by Application in 2019
Figure 88. Egypt Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. Egypt Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 91. South Africa Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 93. Israel Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 95. Turkey Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Stem Cell Drugs Consumption Growth 2015-2020 (K Units)
Figure 97. GCC Countries Stem Cell Drugs Value Growth 2015-2020 ($ Millions)
Figure 98. Global Stem Cell Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 99. Global Stem Cell Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 101. Americas Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 102. APAC Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 103. APAC Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 104. Europe Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 105. Europe Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 107. Middle East & Africa Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 108. United States Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 109. United States Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 110. Canada Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 111. Canada Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 112. Mexico Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 113. Mexico Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 114. Brazil Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 115. Brazil Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 116. China Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 117. China Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 118. Japan Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 119. Japan Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 120. Korea Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 121. Korea Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 123. Southeast Asia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 124. India Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 125. India Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 126. Australia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 127. Australia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 128. Germany Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 129. Germany Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 130. France Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 131. France Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 132. UK Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 133. UK Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 134. Italy Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 135. Italy Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 136. Russia Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 137. Russia Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 138. Spain Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 139. Spain Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 140. Egypt Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 141. Egypt Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 142. South Africa Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 143. South Africa Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 144. Israel Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 145. Israel Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 146. Turkey Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 147. Turkey Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Stem Cell Drugs Consumption 2021-2025 (K Units)
Figure 149. GCC Countries Stem Cell Drugs Value 2021-2025 ($ Millions)
Figure 150. JCR Pharmaceuticals Co., Ltd Stem Cell Drugs Market Share (2018-2020)
Figure 151. CORESTEM, Inc Stem Cell Drugs Market Share (2018-2020)
Figure 152. Anterogen Stem Cell Drugs Market Share (2018-2020)
Figure 153. Chiesi Pharmaceuticals Stem Cell Drugs Market Share (2018-2020)
Figure 154. Pharmicell Co., Ltd Stem Cell Drugs Market Share (2018-2020)
Figure 155. MEDIPOST Stem Cell Drugs Market Share (2018-2020)
Figure 156. Takeda Stem Cell Drugs Market Share (2018-2020)
Figure 157. New York Blood Center Stem Cell Drugs Market Share (2018-2020)
